LB02: Randomized double-blind placebo controlled evaluation of the safety and efficacy of recombinant Antithrombin versus placebo in preterm preeclampsia

Overview of attention for article published in American Journal of Obstetrics & Gynecology, January 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 33,851 followers.

#SMFM17 Late-Breaking Research Abstracts LB02: Recombinant Antithrombin versus placebo in preterm preeclampsia https://t.co/qJriC8Y2Kp https://t.co/gcfMd76lYp

RT @AJOG_thegray: #SMFM17 Late-breaking: Eval of the safety, efficacy of recombinant antithrombin vs placebo in preterm preeclampsia https:…

#SMFM17 Late-breaking: Eval of the safety, efficacy of recombinant antithrombin vs placebo in preterm preeclampsia https://t.co/ImzS8Awby6

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.